Oaktree Acquisition Corp. III Life Sciences (OACC) Notes Payables (2024 - 2026)

Oaktree Acquisition Corp. III Life Sciences has reported Notes Payables for 3 years, with the latest figure at $11824.0 in Q1 2026.

• For the quarter ending Q1 2026, Notes Payables changed 0.0% year-over-year to $11824.0; the trailing twelve-month figure through Mar 2026 stood at $11824.0 (changed 0.0% YoY), and the FY2025 full-year result was $11824.0, changed 0.0% from the prior year.
• Notes Payables for Q1 2026 stood at $11824.0, roughly flat from $11824.0 in the prior quarter.
• The five-year high for Notes Payables was $11824.0 in Q4 2024, with the low at $11824.0 in Q4 2024.
• Historically, Notes Payables has averaged $11824.0 across 3 years, with a median of $11824.0 in 2024.
• The largest YoY upside for Notes Payables was 0.0% in 2025 against a maximum downside of 0.0% in 2025.
• Oaktree Acquisition Corp. III Life Sciences' Notes Payables stood at $11824.0 in 2024, then changed by 0.0% to $11824.0 in 2025, then changed by 0.0% to $11824.0 in 2026.
• The last three Notes Payables figures came in at $11824.0 (Q1 2026), $11824.0 (Q4 2025), and $11824.0 (Q3 2025), per Business Quant data.